Q2 2012 Results (Merrimack) - Aug 10, 2012 - Anticipated presentation of data from P1 monotherapy study for breast cancer by August 2013
Anticipated P1 data • Breast Cancer
|
|
MM 302
---
Merrimack anticipates the following milestones in the next 12 months:
Presentation on a Phase 1 monotherapy study of MM-302
---
(IR 4)
|